Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06098547

LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Azienda Sanitaria Ospedaliera · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

LIRICA is a prospective non-randomized study aimed at exploring the outcome of liver transplantation in selected patients with unresectable iCCA after a downstaging/disease control protocol with standard of care chemotherapy, in terms of overall survival and quality of life. Additionally, the study aims to identify pre-transplant biological markers and clinical factors that can stratify patients with the best post-transplant prognosis. Finally, the study aims to investigate the role of preoperative PET-MR, especially in relation to lymph node locations, by correlating the results with histological examination after iliac lymphadenectomy.

Conditions

Interventions

TypeNameDescription
PROCEDURELiver transplantationPatients will undergo liver transplantation according to the standard procedures of the institutional Center's protocol (cadaveric or living donor transplantation, whole or partial liver). Liver transplantation is preceded by an exploratory laparotomy with clinical evaluation and frozen section examination of lymph nodes in the hepatoduodenal ligament and along the common hepatic artery/celiac axis.

Timeline

Start date
2024-01-15
Primary completion
2028-11-01
Completion
2033-11-01
First posted
2023-10-24
Last updated
2024-01-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06098547. Inclusion in this directory is not an endorsement.